Rosa Maria Iacobazzi

Plasma-activated medium triggers cell death and the presentation of immune activating danger signals in melanoma and pancreatic cancer cells

Amalia Azzariti, Rosa Maria Iacobazzi, R. Fonte et al. · Scientific Reports · 2019 · 156 citations · Full text

Life Sciences, Cancer Biology, Oncology +13

Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma

Simona Serratì, Michele Guida, R. Fonte et al. · Molecular Cancer · 2022 · 148 citations · Full text

Life Sciences, Immunology, Oncology +17

Exploring Basic Tail Modifications of Coumarin-Based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-Soluble, Brain-Permeant Neuroprotective Multitarget Agents

Leonardo Pisani, Roberta Farina, Marco Catto et al. · Journal of Medicinal Chemistry · 2016 · 90 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer

Letizia Porcelli, Rosa Maria Iacobazzi, R. Fonte et al. · Cancers · 2019 · 89 citations · Full text

Medicine, Oncology, Pharmacology +17

Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study

Antonella Argentiero, Simona De Summa, R. Fonte et al. · Cancers · 2019 · 78 citations · Full text

Medicine, Immunology, Oncology +17